Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "A07F" (25)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Antidiarrheal Microorganisms (A07F) 1 products
WHO-DDD
CI
Colibiogen oral
100 ml
PR
PR
k.A.
Solution (oral): Escherichiae coli Lysatum (Stamm Laves) 760-870 mg/ml
Laves-Arzneimittel
Gesellschaft mit
beschränkter Haftung,
Ronnenberg,
Zweigniederlassung
Schötz
D
FB
G
Antidiarrheal Microorganisms (A07FA) 5 products
WHO-DDD
Transfert de microbiote
fécal pour utilisation
allogénique CHUV
2 x 20
PR
PR
k.A.
gélules à libération modifiée: Faeces Humanae Allogenicae 1 g
CHUV Centre
Hospitalier
Universitaire Vaudois
A
FB
G
Transfert de microbiote
fécal pour utilisation
allogénique CHUV
250 ml
PR
PR
k.A.
suspension rectale: Faeces Humanae Allogenicae
CHUV Centre
Hospitalier
Universitaire Vaudois
A
FB
G
L
IP
CI
Mutaflor mite
20 Capsule(s)
9.52
26.75
10 %
Capsules: Escherichia coli viva (Souche: Nissle 1917) 0.5-5
OM Pharma Suisse SA
B / SL
FB
G
L
IP
CI
Mutaflor
20 Capsule(s)
48.52
69.20
10 %
Capsules: Escherichia coli viva (Souche: Nissle 1917) 2.5-25
OM Pharma Suisse SA
B / SL
FB
G
IP
CI
Mutaflor
20 Capsule(s)
PR
PR
k.A.
Capsules: Escherichia coli viva (Souche: Nissle 1917) 2.5-25
OM Pharma Suisse SA
B
FB
G
Lactic Acid Producing Organisms (A07FA01) 7 products
WHO-DDD
IP
CI
Bioflorin
‐
I
25 Capsule(s)
8.87
16.35
k.A.
Capsules: Enterococcus Faecium Vivus (Typus sf 68) 75
Opella Healthcare
Switzerland AG
D
FB
G
IP
CI
Bioflorin
2 x 25 Capsule(s)
PR
PR
k.A.
Capsules: Enterococcus Faecium Vivus (Typus sf 68) 75
Opella Healthcare
Switzerland AG
D
FB
G
IP
CI
Lactoferment 5
‐
I
2 x 10 Capsule(s)
PR
14.95
k.A.
Capsules: Lactobacillus Acidophilus Mortuus Cryodesiccatus (Lactobacillus Fermentum et Lactobacillus Delbrueckii) 5
Gebro Pharma AG
D
FB
G
IP
CI
Lactoferment 10
10 Sachet(s)
PR
PR
k.A.
Sachets: Lactobacillus Acidophilus Mortuus Cryodesiccatus (Lactobacillus Fermentum et Lactobacillus Delbrueckii) 10
Gebro Pharma AG
D
FB
G
IP
CI
Infloran
2 x 10 Capsule(s)
PR
PR
k.A.
Capsules: 2 Active Agents
Desma Healthcare SpA,
Torino succursale di
Chiasso
D
FB
G
IP
CI
Infloran Berna
20 Capsule(s)
PR
19.25
k.A.
Capsules: 2 Active Agents
Berna Biotech AG
D
FB
G
IP
CI
V/S
Lactéol 0.5
6 Tablet(s)
PR
PR
k.A.
Tablets: Lactobacillus Acidophilus Mortuus Tyndallisatus 450 Mio
F. Uhlmann-Eyraud SA
D
FB
G
Saccharomyces Boulardii (A07FA02) 12 products
WHO-DDD
DrugBank.ca
L
IP
Perenterol 500
14
10.72
28.05
10 %
Polvere per sospensione orale: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 500 mg
Zambon Svizzera SA
B / SL
FB
G
IP
CI
Perenterol Lyo-Sol
10
PR
PR
k.A.
polvere per sospensione orale: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D
FB
G
IP
CI
Perenterol Lyo-Sol
14
PR
PR
k.A.
polvere per sospensione orale: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D
FB
G
L
IP
CI
Perenterol 250
10 Capsule(s)
4.67
8.60
10 %
Capsules: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D / SL
FB
G
L
IP
CI
Perenterol 250
20 Capsule(s)
9.35
17.25
10 %
Capsules: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D / SL
FB
G
L
IP
CI
Perenterol 250
10 x 20 Capsule(s)
86.56
159.85
10 %
Capsules: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D / SL
FB
G
L
IP
CI
Perenterol 250
10 Sachet(s)
4.67
8.60
10 %
Polvere per sospensione orale: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D / SL
FB
G
L
IP
CI
Perenterol 250
20 Sachet(s)
9.35
17.25
10 %
Polvere per sospensione orale: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D / SL
FB
G
L
IP
CI
Perenterol 250
10 x 20 Sachet(s)
86.56
159.85
10 %
Polvere per sospensione orale: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D / SL
FB
G
IP
CI
Perenterol 250
20 Capsule(s)
PR
PR
k.A.
Capsules: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D
FB
G
IP
CI
Perenterol travel
8 Capsule(s)
PR
PR
k.A.
Capsula: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D
FB
G
IP
CI
Perenterol travel
12 Capsule(s)
PR
PR
k.A.
Capsula: Saccharomyces Boulardii Cryodesiccatus (Saccharomyces Boulardii cncm I-745) 250 mg
Zambon Svizzera SA
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
